Tissue factor

From Wikipedia, the free encyclopedia
  (Redirected from CD142)
Jump to: navigation, search
Coagulation factor III (thromboplastin, tissue factor)
Protein F3 PDB 1ahw.png
PDB rendering based on 1ahw.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols F3 ; CD142; TF; TFA
External IDs OMIM134390 MGI88381 HomoloGene1511 ChEMBL: 4081 GeneCards: F3 Gene
RNA expression pattern
PBB GE F3 204363 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 2152 14066
Ensembl ENSG00000117525 ENSMUSG00000028128
UniProt P13726 P20352
RefSeq (mRNA) NM_001178096 NM_010171
RefSeq (protein) NP_001171567 NP_034301
Location (UCSC) Chr 1:
94.99 – 95.01 Mb
Chr 3:
121.72 – 121.74 Mb
PubMed search [1] [2]

Tissue factor, also called platelet tissue factor, factor III, thromboplastin, or CD142 is a protein present in subendothelial tissue and leukocytes necessary for the initiation of thrombin formation from the zymogen prothrombin.

This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described.[1] In addition to the membrane-bound tissue factor, soluble form of tissue factor was also found which results from alternatively spliced tissue factor mRNA transcripts, in which exon 5 is absent and exon 4 is spliced directly to exon 6.[2][3]

Structure[edit]

The protein structure of TF consists of three domains:

  1. a domain which is located outside the cell, this domain binds factor VIIa. The binding of VIIa to TF occurs via protein-protein interactions by both molecules.
    1. Factor VIIa is a protein which consists of several domains. One of these domains, the carboxylated GLA domain, binds in the presence of calcium to negatively charged phospholipids. Binding of VIIa to negatively charged phospholipids greatly enhances the protein-protein binding of VIIa to TF.
  2. a domain which crosses the hydrophobic membrane.
  3. a domain of 21 amino acids length inside the cell which is involved in the signaling function of TF.

Functions[edit]

Coagulation[edit]

TF is the cell surface receptor for the serine protease factor VIIa.

The best known function of tissue factor is its role in blood coagulation. The complex of TF with factor VIIa activates factor IX and catalyzes the conversion of the inactive protease factor X into the active protease factor Xa.

Together with factor VIIa, tissue factor forms the tissue factor or extrinsic pathway of coagulation. This is opposed to the intrinsic (amplification) pathway which involves both activated factor IX and factor VIII. Both pathways lead to the activation of factor X (the common pathway) which combines with activated factor V in the presence of calcium and phospholipid to produce thrombin (thromboplastin activity).

The coagulation cascade.

Cytokine[edit]

TF is related to a protein family known as the cytokine receptor class II family. The members of this receptor family are activated by cytokines. Cytokines are small proteins that can influence the behavior of white blood cells. Binding of VIIa to TF has also been found to start signaling processes inside the cell. The signaling function of TF/VIIa plays a role in angiogenesis and apoptosis.

Location[edit]

Some cells release TF in response to blood vessel damage (see next paragraph) and some do only in response to inflammatory mediators (endothelial cells/macrophages).

TF is expressed by cells which are normally not exposed to flowing blood such as sub-endothelial cells (e.g. smooth muscle cells) and cells surrounding blood vessels (e.g. fibroblasts). This can change when the blood vessel is damaged by for example physical injury or rupture of atherosclerotic plaques. Exposure of TF expressing cells during injury allows the complex formation of TF with factor VII. Factor VII and TF form an equal molar complex in the presence of calcium ions and this leads to the activation of factor VII on a membrane surface.

The inner surface of the blood vessel consists of endothelial cells. Endothelial cells do not express TF except when they are exposed to inflammatory molecules such as tumor necrosis factor-alpha (TNF-alpha). Another cell type that expresses TF on the cell surface in inflammatory conditions is the monocyte (a white blood cell).

Thromboplastin[edit]

Historically, thromboplastin was a lab reagent, usually derived from placental sources, used to assay prothrombin times (PT time). Thromboplastin, by itself, could activate the extrinsic coagulation pathway. When manipulated in the laboratory, a derivative could be created called partial thromboplastin. Partial thromboplastin was used to measure the intrinsic pathway. This test is called the aPTT, or activated partial thromboplastin time. It was not until much later that the subcomponents of thromboplastin and partial thromboplastin were identified. Thromboplastin is the combination of both phospholipids and tissue factor, both needed in the activation of the extrinsic pathway, and partial thromboplastin is just phospholipids without tissue factor. Tissue factor is not needed to activate the intrinsic pathway.

Additional images[edit]

Interactions[edit]

Tissue factor has been shown to interact with Factor VII.[4][5]

References[edit]

  1. ^ "Entrez Gene: F3 coagulation factor III (thromboplastin, tissue factor)". 
  2. ^ Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X. (2001). "Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.". Chin Med J (Engl). 114 (1): 30–4. PMID 11779431. 
  3. ^ Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y (April 2003). "Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein". Nat. Med. 9 (4): 458–62. doi:10.1038/nm841. PMID 12652293. 
  4. ^ Carlsson, Karin; Freskgård Per-Ola; Persson Egon; Carlsson Uno; Svensson Magdalena (Jun 2003). "Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor". Eur. J. Biochem. (Germany) 270 (12): 2576–82. doi:10.1046/j.1432-1033.2003.03625.x. ISSN 0014-2956. PMID 12787023. 
  5. ^ Zhang, E; St Charles R; Tulinsky A (Feb 1999). "Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant". J. Mol. Biol. (ENGLAND) 285 (5): 2089–104. doi:10.1006/jmbi.1998.2452. ISSN 0022-2836. PMID 9925787. 

Further reading[edit]

  • Gouault-Helimann M, Josso F (1980). "[Initiation in vivo of blood coagulation. The role of white blood cells and tissue factor (author's transl)]". La Nouvelle presse médicale 8 (40): 3249–53. PMID 392457. 
  • Mackman N (1995). "Regulation of the tissue factor gene.". FASEB J. 9 (10): 883–9. PMID 7615158. 
  • McVey JH (2000). "Tissue factor pathway.". Baillieres Best Pract. Res. Clin. Haematol. 12 (3): 361–72. PMID 10856975. 
  • Konigsberg W, Kirchhofer D, Riederer MA, Nemerson Y (2002). "The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis.". Thromb. Haemost. 86 (3): 757–71. PMID 11583305. 
  • Versteeg HH, Peppelenbosch MP, Spek CA (2002). "The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?". Thromb. Haemost. 86 (6): 1353–9. PMID 11776298. 
  • Fernandez PM, Rickles FR (2003). "Tissue factor and angiogenesis in cancer.". Curr. Opin. Hematol. 9 (5): 401–6. doi:10.1097/00062752-200209000-00003. PMID 12172458. 
  • Golino P (2003). "The inhibitors of the tissue factor:factor VII pathway.". Thromb. Res. 106 (3): V257–65. doi:10.1016/S0049-3848(02)00079-8. PMID 12356487. 
  • Engelmann B, Luther T, Müller I (2004). "Intravascular tissue factor pathway--a model for rapid initiation of coagulation within the blood vessel.". Thromb. Haemost. 89 (1): 3–8. doi:10.1267/THRO03010003 (inactive 2010-06-23). PMID 12540946. 
  • Morrissey JH (2004). "Tissue factor: in at the start...and the finish?". J. Thromb. Haemost. 1 (5): 878–80. doi:10.1046/j.1538-7836.2003.00219.x. PMID 12871349. 
  • Yu JL, May L, Klement P et al. (2004). "Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy". Semin. Thromb. Hemost. 30 (1): 21–30. doi:10.1055/s-2004-822968. PMID 15034795. 
  • Fernandez PM, Patierno SR, Rickles FR (2004). "Tissue factor and fibrin in tumor angiogenesis". Semin. Thromb. Hemost. 30 (1): 31–44. doi:10.1055/s-2004-822969. PMID 15034796. 
  • Mackman N (2004). "Role of tissue factor in hemostasis, thrombosis, and vascular development". Arterioscler. Thromb. Vasc. Biol. 24 (6): 1015–22. doi:10.1161/01.ATV.0000130465.23430.74. PMID 15117736. 
  • Belting M, Ahamed J, Ruf W (2005). "Signaling of the tissue factor coagulation pathway in angiogenesis and cancer". Arterioscler. Thromb. Vasc. Biol. 25 (8): 1545–50. doi:10.1161/01.ATV.0000171155.05809.bf. PMID 15905465. 
  • Engelmann B (2007). "Initiation of coagulation by tissue factor carriers in blood". Blood Cells Mol. Dis. 36 (2): 188–90. doi:10.1016/j.bcmd.2005.12.020. PMID 16473535. 
  • Furie B, Furie BC (2007). "Cancer-associated thrombosis". Blood Cells Mol. Dis. 36 (2): 177–81. doi:10.1016/j.bcmd.2005.12.018. PMID 16490369. 
  • Mackman N (2007). "Alternatively spliced tissue factor - one cut too many?". Thromb. Haemost. 97 (1): 5–8. doi:10.1160/th06-11. PMID 17200762. 
  • Wiiger MT, Prydz H (2007). "The changing faces of tissue factor biology. A personal tribute to the understanding of the "extrinsic coagulation activation"". Thromb. Haemost. 98 (1): 38–42. doi:10.1160/th07-04-0289. PMID 17597988. 

See also[edit]